- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/74 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
Patent holdings for IPC class C07C 235/74
Total number of patents in this class: 162
10-year publication summary
|
14
|
17
|
12
|
6
|
13
|
6
|
6
|
11
|
7
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 456 |
10 |
| Celanese International Corporation | 910 |
7 |
| BASF SE | 20945 |
6 |
| Kthera, LLC | 7 |
5 |
| Bedoukian Research, Inc. | 98 |
4 |
| Givaudan SA | 1889 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 830 |
4 |
| Acuitas Therapeutics Inc. | 115 |
3 |
| Cornell University | 3314 |
3 |
| MedImmune Limited | 617 |
3 |
| Rhodia Operations | 1587 |
3 |
| Saudi Arabian Oil Company | 13263 |
3 |
| The University of British Columbia | 1497 |
3 |
| Bristol-myers Squibb Company | 4881 |
2 |
| LG Chem, Ltd. | 17641 |
2 |
| Ajinomoto Co., Inc. | 2294 |
2 |
| Northwestern University | 3401 |
2 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
2 |
| Daicel Corporation | 2354 |
2 |
| Egis Gyogyszergyar Rt. | 54 |
2 |
| Other owners | 90 |